Ibm Retirement Fund Lifted Edwards Lifesciences (EW) Holding; CADUS CORPORATION (KDUS) Shorts Raised By 4.31%

November 15, 2017 - By Clifton Ray

CADUS CORPORATION (OTCMKTS:KDUS) had an increase of 4.31% in short interest. KDUS’s SI was 12,100 shares in November as released by FINRA. Its up 4.31% from 11,600 shares previously. With 47,200 avg volume, 0 days are for CADUS CORPORATION (OTCMKTS:KDUS)’s short sellers to cover KDUS’s short positions. It closed at $1.27 lastly. It is down 0.00% since November 15, 2016 and is . It has underperformed by 16.70% the S&P500.

Ibm Retirement Fund increased Edwards Lifesciences Corp (EW) stake by 116.36% reported in 2017Q2 SEC filing. Ibm Retirement Fund acquired 2,739 shares as Edwards Lifesciences Corp (EW)’s stock rose 25.80%. The Ibm Retirement Fund holds 5,093 shares with $674,000 value, up from 2,354 last quarter. Edwards Lifesciences Corp now has $22.25 billion valuation. The stock decreased 0.06% or $0.06 during the last trading session, reaching $105.15. About shares traded. Edwards Lifesciences Corp (NYSE:EW) has risen 15.41% since November 15, 2016 and is uptrending. It has underperformed by 1.29% the S&P500.

Among 27 analysts covering Edwards Lifesciences Corp (NYSE:EW), 20 have Buy rating, 1 Sell and 6 Hold. Therefore 74% are positive. Edwards Lifesciences Corp has $195 highest and $86 lowest target. $121.80’s average target is 15.83% above currents $105.15 stock price. Edwards Lifesciences Corp had 84 analyst reports since July 30, 2015 according to SRatingsIntel. The company was maintained on Friday, September 1 by RBC Capital Markets. Bank of America upgraded Edwards Lifesciences Corp (NYSE:EW) on Thursday, July 27 to “Buy” rating. The rating was maintained by Morgan Stanley with “Overweight” on Thursday, October 26. Bank of America upgraded Edwards Lifesciences Corp (NYSE:EW) on Wednesday, July 27 to “Buy” rating. The rating was maintained by Citigroup with “Sell” on Wednesday, April 27. The company was maintained on Monday, October 2 by RBC Capital Markets. Canaccord Genuity maintained Edwards Lifesciences Corp (NYSE:EW) rating on Monday, September 4. Canaccord Genuity has “Buy” rating and $155.0 target. RBC Capital Markets maintained the shares of EW in report on Wednesday, February 3 with “Outperform” rating. RBC Capital Markets maintained it with “Buy” rating and $12000 target in Tuesday, May 30 report. Credit Suisse reinitiated Edwards Lifesciences Corp (NYSE:EW) rating on Monday, August 10. Credit Suisse has “Outperform” rating and $162 target.

Cadus Corporation is engaged in the purchase of homes and land for purposes of renovation or construction and resale. The company has market cap of $33.39 million. The Company, through its subsidiaries, owns approximately 12 single-family residential zoned properties in Miami-Dade County, Florida. It currently has negative earnings. The Firm also owns an approximately one-acre single-family residential zoned vacant lot in East Hampton, New York.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com